Biovica International AB (publ) (STO:BIOVIC.B)
Sweden · Delayed Price · Currency is SEK 0.3330
0.00 (0.00%)
May 21, 2026, 10:21 AM CET
Biovica International AB Market Cap
Biovica International AB has a market cap or net worth of 97.21 million as of May 21, 2026. Its market cap has increased by 42.01% in one year.
Market Cap
97.21M
Enterprise Value
13.82M
Revenue
10.93M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.33
Market Cap Chart
Since March 29, 2017, Biovica International AB's market cap has decreased from 210.00M to 97.21M, a decrease of -53.71%. That is a compound annual growth rate of -8.08%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 20, 2026 | 97.21M | -10.00% |
| Dec 30, 2025 | 108.01M | -44.77% |
| Dec 30, 2024 | 195.57M | -9.82% |
| Dec 29, 2023 | 216.86M | -41.83% |
| Dec 30, 2022 | 372.79M | -68.37% |
| Dec 30, 2021 | 1.18B | -18.58% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Mar 29, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Simris Group AB (PUBL) | 141.05M |
| Alligator Bioscience AB | 140.70M |
| Magle Chemoswed Holding AB | 119.55M |
| NextCell Pharma AB | 118.30M |
| IRLAB Therapeutics AB | 107.70M |
| Annexin Pharmaceuticals AB | 105.18M |
| AcouSort AB | 103.28M |
| Scandinavian ChemoTech AB | 92.91M |